In support of glucagon catabolic effects, we subsequently found that either Ax or Reg administration hardly affected tumor growth but significantly improved the weight loss, glucose intolerance, loss of fat and muscle tissues, and forelimb weakness in ApcMin/+ mice (Fig. 7c‒I and Supplementary Fig. S10d, h). Here, GCG is linked to neoplasm.